NCT00408538View on ClinicalTrials.gov

Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2006

Study Completion Date

April 30, 2008

Conditions
HIV Infections
Interventions
DRUG

UC-781 microbicide gel (0.1% and 0.25%)

DRUG

placebo

Trial Locations (1)

90024

UCLA Center for HIV Prevention Research, Los Angeles

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

CONRAD

OTHER

lead

University of California, Los Angeles

OTHER

NCT00408538 - Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally | Biotech Hunter | Biotech Hunter